FAP and neoplasm: A separate case series of nine patients with high FAP expressing advanced solid tumors treated with 90Y-FAPI-46 reported favorable tumor uptake and disease control in ~50% of patients, although grade 3–4 hematologic toxicity occurred in four cases [188].